HIV – Discover Pharma

Welcome to Discover Pharma! Today is : September 16, 2026

HIV

Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
FDA approves Tivicay PD for children with HIV weighing at least 2kg
ViiV Healthcare has received US FDA approval for Tivicay PD [...]

September 4, 2026
Clinical & Regulatory
European HIV survey finds gap in long-acting treatment conversations
A European survey of more than 1,900 people living with [...]

July 29, 2026
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
ViiV Healthcare HIV regimen Dovato non-inferior to Biktarvy in Phase 3b study
ViiV Healthcare’s two-drug HIV regimen Dovato was non-inferior to the [...]

July 28, 2026
Biotech & Pharma Business,Opinion & Events
Pioneering consultant Dr Rageshri Dhairyawan wins 2025 Gilead & Kite campaigner for health equity award
NHS consultant and author Dr Rageshri Dhairyawan has been awarded [...]

May 5, 2026
Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events
Most people with HIV choose long-acting injectables over daily pills
Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK